Related Experiment Video

Updated: Jun 13, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways

Nameeta Mujumdar1, Tiffany N Mackenzie, Vikas Dudeja

  • 1Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

Gastroenterology
|May 4, 2010
PubMed
Abstract

Insights

Triptolide kills pancreatic cancer cells through apoptosis or autophagy, depending on the cell line. This dual-action mechanism makes triptolide a promising agent against various pancreatic cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic adenocarcinoma is a lethal cancer with limited treatment options.
  • Triptolide has previously demonstrated efficacy in inhibiting pancreatic cancer cell growth.
  • This study elucidates the specific mechanisms of triptolide-induced cancer cell death.

Purpose of the Study:

  • To investigate the molecular mechanisms by which triptolide induces cell death in pancreatic cancer.
  • To differentiate between apoptotic and autophagic pathways activated by triptolide.
  • To assess the potential of triptolide as a chemotherapeutic agent for pancreatic cancer.

Main Methods:

  • Cell viability and caspase-3 activity assays were performed.
  • Flow cytometry was used to analyze apoptosis and autophagy markers (Annexin V, propidium iodide, acridine orange).
  • Immunofluorescence monitored cytochrome c and LC3 protein localization; gene silencing targeted key apoptosis and autophagy proteins (Caspase-3, Atg5, Beclin1).

Main Results:

  • Triptolide induced apoptosis in MiaPaCa-2, Capan-1, and BxPC-3 cells.
  • Triptolide induced autophagy in S2-013, S2-VP10, and Hs766T cells, which contributed to cell death.
  • Autophagy activation involved Atg5/Beclin1, Akt/mTOR inactivation, and ERK1/2 activation; inhibiting autophagy led to apoptosis, while inhibiting both pathways rescued cell death.

Conclusions:

  • Triptolide triggers pancreatic cancer cell death via distinct pathways: apoptosis or autophagy.
  • The specific pathway (apoptosis vs. autophagy) is cell line-dependent.
  • Triptolide's ability to induce death through multiple mechanisms positions it as a versatile therapeutic candidate for pancreatic cancer.

More Related Videos

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation06:12

LPS and ATP-induced Death of PMA-differentiated THP-1 Macrophages and its Validation

Published on: May 3, 2024

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...